Ernst & Young, pdf, 430 KB
GATC Biotech is Europe’s leading service provider of DNA sequencing with more than 10.000 academic and industrial customers worldwide. For over two decades, we have offered sequencing and bioinformatics solutions from single samples up to large scale projects. GATC Biotech has sequenced more than 6 million samples, ten thousands of bacterial, plant and other whole genomes as well as hundreds of whole human genomes.
Having Agilent and Illumina Certified Service Provider status, GATC Biotech offers true multiplatform sequencing using all leading sequencing technologies in its own labs: Sanger Sequencing with a fleet of 16 ABI 3730xl, Next and Third Generation Sequencing on several Roche GS FLX System, Illumina HiSeq 2500, Illumina MiSeq and Pacific Biosciences’ PacBio RS II.
In order to evaluate these immense data quantities professionally, GATC Biotech keeps its own IT farm. It consists of over 160 servers – that is more than 900 processors in total. In addition, there is over 1,8TB main memory and 360TB fix-disk storage available. For instance, the Illumina HiSeq 2000s generate up to 8TB per week of new data which is analyzed by the High Performance Cluster.
Headquartered in Constance, Germany, the company houses its ISO 17025 certified Genome and Diagnostic Centre with a focus on Next and Third Generation sequencing. Cologne-Bonn Cargo as logistical hub in striking distance, it's the ideal location for our European Custom Sequencing Center focusing on all time-critical Sanger sequencing services. All laboratories have highly integrated and fully automatic processing pipelines and enable full compliance with latest state-of-the-art quality standards. Since 2010, GATC Biotech has been a key supplier for the International Cancer Genome Project.
GATC Biotech´s subsidiary LifeCodexx emphasises the development of clinically validated molecular diagnostic tests and offers a risk-free alternative to common invasive examination methods such as amniocentesis.
From left to right: Peter Pohl (CEO), Thomas Pohl (CTO), Dr. Marcus Benz (COO)
(for CVs click on images)